Are clinical trials safe?

Yes. Every study on QualifiedStudies is reviewed and approved by an Institutional Review Board (IRB) and conducted under FDA regulations. Research sites are HIPAA-covered entities, and you can withdraw at any time for any reason.

Do I get paid to participate in a clinical trial?

Most studies offer compensation for your time and travel. The amount varies by study length and visit schedule, and is disclosed up front before you enroll.

Is my health information kept private?

Yes. Your information is encrypted, never sold, and only shared with the specific research site you choose to apply to. Our handling of your data is governed by our Consumer Health Data Privacy Policy; the research sites you're matched with are HIPAA-covered entities.

How do I qualify for a clinical trial?

Take our free 60-second eligibility quiz. Enter your ZIP code, condition, and a few health details, and we'll match you with research sites near you that are actively enrolling participants.

Modifying PEST for Psoriatic Arthritis Screening

NCT ID: NCT06382051
Registry status: Recruiting
Study type: Not specified in the registry data
Phase: Not applicable
Sponsor: Novartis Pharmaceuticals

Overview

ClinicalTrials.gov lists this study as Recruiting.

Enrollment: 502 participants (Estimated).

What is being studied

No interventions are listed in the registry data.

Who may be eligible

Ages: Not specified in the registry data
Sex: Not specified in the registry data
Healthy volunteers accepted: Yes

ClinicalTrials.gov lists the following eligibility criteria.

Key inclusion criteria: 1. Moderate-to-severe plaque PsO patients who are candidates for bDMARDs, according to physician's clinical judgement at the time of patient enrollment. 2. Adult patients at the time of informed consent signature 3. Patients able to understand and willing to comply with protocol requirements, instructions, and restrictions 4. Residents of Canada Key exclusion criteria: 1. Patients who have previously screened positive for PsA through PEST. 2. Patients who have been diagnosed with PsA. 3. Patients who have been diagnosed with inflammatory arthritis unrelated to PsA (rheumatoid arthritis, reactive arthritis, enteropathic arthritis, axial spondyloarthritis) 4. Patients treated with a bDMARD for moderate-to-severe plaque PsO or any other medical condition within the last 6 months prior to patient enrollment.

Study locations

21 study locations are listed.

Site recruitment status is not specified in the registry data for these locations.

Countries: Canada

Alberta, Canada: 2
British Columbia, Canada: 2
Manitoba, Canada: 1
New Brunswick, Canada: 1
Ontario, Canada: 10
Quebec, Canada: 4
Saskatchewan, Canada: 1

Sample of listed locations

Novartis Investigative Site — Calgary, Alberta, T2J 7E1, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Edmonton, Alberta, T5J 3S9, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Kelowna, British Columbia, V1W 4V5, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Surrey, British Columbia, V3R 6A7, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Winnipeg, Manitoba, R3C 0N2, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Fredericton, New Brunswick, E3B 1G9, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Barrie, Ontario, L4M 6L2, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Greater Sudbury, Ontario, P3C 1X8, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Hamilton, Ontario, L8J 0G5, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — London, Ontario, N6A 5R9, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Markham, Ontario, L3R 2C7, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Ottawa, Ontario, K2A 3Z3, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Richmond Hill, Ontario, L4C 9M7, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Stoney Creek, Ontario, L8G 1H1, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Toronto, Ontario, M4A2S8, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Waterloo, Ontario, N2J 1C4, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Montreal, Quebec, H1T 2M4, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Québec, Quebec, G1V 4X7, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Ste-Foy, Quebec, G1V 4G2, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Verdun, Quebec, H4G 3E7, Canada — Site recruitment status not specified in the registry data
Novartis Investigative Site — Saskatoon, Saskatchewan, S7K 2C1, Canada — Site recruitment status not specified in the registry data

Study details

Start date: January 23, 2025
Primary completion date: December 31, 2026
First posted: April 24, 2024

Source and update information

Source: ClinicalTrials.gov
NCT ID: NCT06382051
Registry last updated: September 9, 2026
QualifiedStudies registry data refreshed: September 21, 2026

View NCT06382051 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Arthritis studies | Clinical trial FAQ